Moreover, plasma LDHA, CCL2, and CCL7 levels were not related to the status of recurrence, gender, age, and MGMT methylation in glioblastoma patients (Supplementary Fig. S16a–l). This evidence concerns the gene CCL7 and glioblastoma.